The Food and Drug Administration, in a written warning, has taken issue with Pfizer for failing to tell people about risks from the drugs Caduet, Norvasc and Chantix. The warning comes after the agency received a tip about the way various drugs were being marketed on the pharmaceutical giant’s Web site.
According to the FDA, links on the Web pages detailing the individual drugs describes only what the pills do omitting their risks. "By omitting the most serious and frequently occurring risks associated with Caduet, Chantix, and Norvasc, the webpage misleadingly suggests that these drugs are safer than have been demonstrated," the FDA wrote in the letter.
Caduet is used to treat high cholesterol and blood pressure and Norvasc is taken for high blood pressure as well. The drug Chantix is a pill to help people quit smoking. Pfizer has until Sept. 14 to respond to the FDA's letter.
Messa & Associates is available to handle cases involving injuries related to the drugs Caduet, Norvasc and Chantix. Our attorneys are experienced at handling cases involving drugs and drug product injuries and have successfully pursued litigation and obtained verdicts and settlements for victims suffering from these injuries. If you or a loved one has taken Pfizer’s drug Caduet, Norvasc or Chantix and suffered a serious illness as a result of doing so, please contact us at 1-877-MessaLaw.
No comments:
Post a Comment